Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Fiber blends, often proprietary mixtures of soluble and insoluble fibers, have a moderate degree of scientific support for use in reducing certain side effects of cancer treatment, particularly gastrointestinal (GI) side effects. Cancer therapies, especially chemotherapy and radiation, frequently cause GI disturbances such as diarrhea, constipation, and mucositis. Several clinical studies and meta-analyses indicate that soluble fibers (such as inulin, psyllium, and partially hydrolyzed guar gum) may help manage chemotherapy-induced diarrhea and improve bowel regularity. Some evidence also suggests that fiber can benefit the gut microbiome, which is often disrupted during cancer treatment and may contribute to side effects. For example, a 2021 review in "Current Oncology Reports" notes that prebiotic fibers can promote beneficial bacteria, potentially reducing inflammation and improving gut health during therapy. However, the evidence is not uniform: not all fiber blends are equally effective, and some patients may experience worsened symptoms if fiber is not introduced appropriately. Furthermore, studies often focus on individual fibers rather than proprietary blends, and there is variability in patient response depending on cancer type, treatment regimen, and baseline GI function. In conclusion, while fiber blends are not a cure, there is moderate scientific evidence supporting their use to reduce certain GI side effects of cancer treatment, especially when tailored to individual patient needs and introduced under clinical supervision.

More about fiber blend (proprietary)
More about Cancer Treatment (reducing side effects)

Other ingredients used for Cancer Treatment (reducing side effects)

Other health conditions supported by fiber blend (proprietary)

Products containing fiber blend (proprietary)

Vitabase Suprema Dophilus Multi Probiotic
Douglas Laboratories Ultra Protein Green